What is the term for blood in semen (hematospermia) and what are its possible causes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood in Semen: Hematospermia

Blood in semen is called hematospermia (or hemospermia), and it is most commonly caused by infectious/inflammatory conditions of the urogenital tract (accounting for approximately 40% of cases), with iatrogenic trauma from prostate biopsies being the single most common identifiable cause overall. 1

What is Hematospermia?

Hematospermia is defined as the presence of blood in the ejaculate or semen. 1 While it causes significant anxiety for patients due to fears of malignancy or venereal disease, it is typically a benign and self-limiting condition, particularly in younger men. 1

Common Causes

Most Frequent Etiologies

Iatrogenic causes are the most common overall:

  • Transrectal ultrasound-guided prostate biopsy is the single most common cause of hematospermia 2, 3
  • This is a predictable consequence of prostatic procedures 4

Infectious/inflammatory conditions are the most common non-iatrogenic cause:

  • Account for approximately 40% of all hematospermia cases 1
  • Most common etiology in men <40 years of age 1
  • Include prostatitis, seminal vesiculitis, urethritis, and epididymitis 1, 5
  • Common pathogens include Escherichia coli and Chlamydia trachomatis 5

Anatomic and Structural Causes

Hematospermia may originate from pathology in multiple locations 1:

  • Prostate gland: prostatic calculi, cysts, benign prostatic hypertrophy 1
  • Seminal tract: seminal vesicles (a main site of bleeding), vasa deferentia, ejaculatory ducts 1
  • Other structures: verumontanum, urethra, urinary bladder, epididymis, testes 1
  • Specific lesions: ductal obstruction, ejaculatory duct obstruction, prostatic cyst formation 1
  • Vascular abnormalities: rarely, vascular malformations 1

Less Common but Important Causes

  • Malignancy: Prostate, testicular, and other genitourinary cancers are rarely the cause of hematospermia 2, 3
  • Systemic conditions: arterial hypertension, hematologic disorders, coagulation abnormalities 4
  • Idiopathic: While historically most cases were labeled idiopathic, improved imaging has significantly decreased this category 1

Clinical Approach by Patient Age and Presentation

Men <40 Years with Transient/Single Episode

Watchful waiting and reassurance are appropriate for young men with a single episode and no other symptoms. 1

Essential evaluation includes 1:

  • Detailed history focusing on: timing of blood appearance, sexual history, recent procedures, systemic symptoms
  • Physical examination including: blood pressure measurement, abdominal palpation for organomegaly, genital examination for testicular masses or urethral discharge, digital rectal examination of prostate 1
  • Basic laboratory testing: urinalysis, urine culture, visual semen analysis, complete blood count, coagulation studies 1

Imaging is NOT indicated for this population as the condition is typically benign and self-limiting. 1

Men ≥40 Years OR Persistent/Symptomatic Hematospermia

All patients ≥40 years should be screened for prostate cancer with prostate-specific antigen (PSA) testing. 1

Transrectal ultrasound (TRUS) is the first-line imaging modality (ACR appropriateness rating: 8/9). 1

TRUS advantages 1:

  • Safe, inexpensive, radiation-free, effective
  • Detects abnormalities in 82-95% of men with hematospermia 1
  • Can identify: calcifications/calculi, cysts, benign prostatic hypertrophy, prostatitis, Cowper gland masses 1
  • Allows TRUS-guided aspiration or biopsy if needed 1

MRI pelvis is indicated when TRUS is negative or inconclusive (ACR appropriateness rating: 7-8/9). 1

MRI advantages 1:

  • Superior soft tissue contrast and multiplanar capability
  • Operator-independent (unlike TRUS)
  • Better for determining organ of origin of cysts and evaluating ejaculatory duct obstruction 1
  • Can assess for suspected prostate cancer (should include dynamic contrast-enhanced sequences) 1

Important Clinical Pitfalls

Common age-related findings may not be causative: Benign prostatic hyperplasia and prostatic calcifications are age-related changes that can be found in asymptomatic patients and may not explain the hematospermia. 1

Partner bleeding can be mistaken for hematospermia: Always determine the true origin of bleeding through careful history, as postcoital hemorrhage from a sexual partner may be confused with hematospermia. 1

Hematospermia in epididymitis appears early: In patients developing acute epididymitis, hematospermia may appear as early as 24 hours before scrotal symptoms develop (occurs in 15% of cases). 5

PSA elevation is expected: Hematospermia itself can cause elevated PSA levels (median 3.1 ng/mL in epididymitis patients with hematospermia vs 1.8 ng/mL without). 5

Imaging Modalities to Avoid

CT scanning is usually NOT appropriate (ACR appropriateness rating: 1-2/9) due to radiation exposure and poor soft tissue contrast for differentiating prostatic and seminal tract pathology. 1

Pelvic angiography is reserved only for intractable hematospermia when all other evaluations are unrevealing, and can provide therapeutic embolization if vascular malformation is identified. 1

Sexual and Fertility Implications

Hematospermia has several important consequences 2, 3:

  • Causes significant anxiety affecting libido
  • May increase risk of erectile dysfunction
  • Can compromise fertility, particularly when cryopreservation is needed
  • Persistent hematospermia at 14 days post-infection is associated with massive leukocytospermia, reduced sperm concentration, and abnormal seminal markers 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.